• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR-Cas9 核糖核蛋白和 AAV 供体介导的 NHEJ、MMEJ 和 HDR 编辑的动力学和竞争。

Dynamics and competition of CRISPR-Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing.

机构信息

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Department of Pathology and Human Anatomy, Loma Linda University, Loma Linda, CA 92350, USA.

出版信息

Nucleic Acids Res. 2021 Jan 25;49(2):969-985. doi: 10.1093/nar/gkaa1251.

DOI:10.1093/nar/gkaa1251
PMID:33398341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7826255/
Abstract

Investigations of CRISPR gene knockout editing profiles have contributed to enhanced precision of editing outcomes. However, for homology-directed repair (HDR) in particular, the editing dynamics and patterns in clinically relevant cells, such as human iPSCs and primary T cells, are poorly understood. Here, we explore the editing dynamics and DNA repair profiles after the delivery of Cas9-guide RNA ribonucleoprotein (RNP) with or without the adeno-associated virus serotype 6 (AAV6) as HDR donors in four cell types. We show that editing profiles have distinct differences among cell lines. We also reveal the kinetics of HDR mediated by the AAV6 donor template. Quantification of T50 (time to reach half of the maximum editing frequency) indicates that short indels (especially +A/T) occur faster than longer (>2 bp) deletions, while the kinetics of HDR falls between NHEJ (non-homologous end-joining) and MMEJ (microhomology-mediated end-joining). As such, AAV6-mediated HDR effectively outcompetes the longer MMEJ-mediated deletions but not NHEJ-mediated indels. Notably, a combination of small molecular compounds M3814 and Trichostatin A (TSA), which potently inhibits predominant NHEJ repairs, leads to a 3-fold increase in HDR efficiency.

摘要

CRISPR 基因敲除编辑谱的研究有助于提高编辑结果的精确性。然而,特别是对于同源定向修复(HDR),在临床相关细胞(如人类 iPSC 和原代 T 细胞)中,其编辑动力学和模式仍知之甚少。在这里,我们研究了 Cas9 指导 RNA 核糖核蛋白(RNP)递送后,在四种细胞类型中,有无腺相关病毒血清型 6(AAV6)作为 HDR 供体时的编辑动力学和 DNA 修复谱。我们发现编辑谱在细胞系之间存在明显差异。我们还揭示了 AAV6 供体模板介导的 HDR 动力学。T50(达到最大编辑频率一半的时间)的定量表明,短插入缺失(尤其是 +A/T)比更长的缺失(>2 bp)发生得更快,而 HDR 的动力学介于非同源末端连接(NHEJ)和微同源介导的末端连接(MMEJ)之间。因此,AAV6 介导的 HDR 有效地与更长的 MMEJ 介导的缺失竞争,但不能与 NHEJ 介导的插入缺失竞争。值得注意的是,小分子化合物 M3814 和 Trichostatin A(TSA)的组合,能够强烈抑制主要的 NHEJ 修复,可使 HDR 效率提高 3 倍。

相似文献

1
Dynamics and competition of CRISPR-Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing.CRISPR-Cas9 核糖核蛋白和 AAV 供体介导的 NHEJ、MMEJ 和 HDR 编辑的动力学和竞争。
Nucleic Acids Res. 2021 Jan 25;49(2):969-985. doi: 10.1093/nar/gkaa1251.
2
Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing.CRISPR-Cas9 引导 RNA 的合理选择用于同源定向基因组编辑。
Mol Ther. 2021 Mar 3;29(3):1057-1069. doi: 10.1016/j.ymthe.2020.10.006. Epub 2020 Oct 14.
3
Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors.组蛋白去乙酰化酶抑制剂增强 CRISPR/Cas9 介导的同源定向 DNA 修复。
Int J Biochem Cell Biol. 2020 Aug;125:105790. doi: 10.1016/j.biocel.2020.105790. Epub 2020 Jun 10.
4
Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.通过 CRISPR-Cas9 介导的非同源性靶向整合在人造血干/祖细胞中进行基因组编辑。
Mol Ther. 2021 Apr 7;29(4):1611-1624. doi: 10.1016/j.ymthe.2020.12.010. Epub 2020 Dec 10.
5
Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.促进同源定向修复选择的方法以应对 CRISPR/Cas9 诱导的双链断裂。
Int J Mol Sci. 2020 Sep 4;21(18):6461. doi: 10.3390/ijms21186461.
6
Improved and Flexible HDR Editing by Targeting Introns in iPSCs.通过靶向 iPS 细胞中的内含子实现改进和灵活的 HDR 编辑。
Stem Cell Rev Rep. 2022 Jun;18(5):1822-1833. doi: 10.1007/s12015-022-10331-1. Epub 2022 Jan 28.
7
Gene Disruption Using CRISPR-Cas9 Technology.使用CRISPR-Cas9技术进行基因敲除
Methods Mol Biol. 2019;1881:201-209. doi: 10.1007/978-1-4939-8876-1_16.
8
Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.用于哺乳动物细胞系功能研究的通用且精确的基因靶向策略。
Methods. 2017 May 15;121-122:45-54. doi: 10.1016/j.ymeth.2017.05.003. Epub 2017 May 10.
9
Effective control of large deletions after double-strand breaks by homology-directed repair and dsODN insertion.通过同源定向修复和 dsODN 插入有效控制双链断裂后的大片段缺失。
Genome Biol. 2021 Aug 20;22(1):236. doi: 10.1186/s13059-021-02462-4.
10
Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing.对同源定向修复(HDR)和非同源末端连接(NHEJ)的系统定量揭示了基因座、核酸酶和细胞类型对基因组编辑的影响。
Sci Rep. 2016 Mar 31;6:23549. doi: 10.1038/srep23549.

引用本文的文献

1
Gene editing in hematopoietic stem cells by co-delivery of Cas9/sgRNA ribonucleoprotein and templates for homology-directed repair in 'all-in-one' lentivirus-derived nanoparticles.通过在“一体化”慢病毒衍生纳米颗粒中共递送Cas9/sgRNA核糖核蛋白和同源定向修复模板,对造血干细胞进行基因编辑。
Nucleic Acids Res. 2025 Aug 11;53(15). doi: 10.1093/nar/gkaf767.
2
Controlling CRISPR-Cas9 genome editing in human cells using a molecular glue degrader.使用分子胶降解剂控制人类细胞中的CRISPR-Cas9基因组编辑。
Mol Ther Nucleic Acids. 2025 Jul 21;36(3):102640. doi: 10.1016/j.omtn.2025.102640. eCollection 2025 Sep 9.
3
Refined DNA repair manipulation enables a universal knock-in strategy in mouse embryos.

本文引用的文献

1
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.CRISPR-Cas9 基因编辑治疗镰状细胞病和 β-地中海贫血。
N Engl J Med. 2021 Jan 21;384(3):252-260. doi: 10.1056/NEJMoa2031054. Epub 2020 Dec 5.
2
Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku-DNA interaction.通过靶向独特的 Ku-DNA 相互作用发现和开发新型 DNA-PK 抑制剂。
Nucleic Acids Res. 2020 Nov 18;48(20):11536-11550. doi: 10.1093/nar/gkaa934.
3
Metabolic engineering generates a transgene-free safety switch for cell therapy.
优化的DNA修复操作可实现小鼠胚胎中的通用敲入策略。
Nat Commun. 2025 Jul 15;16(1):6502. doi: 10.1038/s41467-025-61696-z.
4
Strategies for CRISPR-based knock-ins in primary human B cells and lymphoma cell lines.基于CRISPR技术在原代人B细胞和淋巴瘤细胞系中进行基因敲入的策略。
Front Immunol. 2025 May 16;16:1589729. doi: 10.3389/fimmu.2025.1589729. eCollection 2025.
5
CRISPR/Cas9 Ribonucleoprotein Delivery Enhanced by Lipo-Xenopeptide Carriers and Homology-Directed Repair Modulators: Insights from Reporter Cell Lines.脂质-异种肽载体和同源定向修复调节剂增强CRISPR/Cas9核糖核蛋白递送:来自报告细胞系的见解
Int J Mol Sci. 2025 May 3;26(9):4361. doi: 10.3390/ijms26094361.
6
Comparative analysis of multiple DNA double-strand break repair pathways in CRISPR-mediated endogenous tagging.CRISPR介导的内源性标记中多种DNA双链断裂修复途径的比较分析
Commun Biol. 2025 May 13;8(1):749. doi: 10.1038/s42003-025-08187-5.
7
Application of CRISPR-Cas9 in microbial cell factories.CRISPR-Cas9在微生物细胞工厂中的应用。
Biotechnol Lett. 2025 Apr 21;47(3):46. doi: 10.1007/s10529-025-03592-6.
8
Engineering adeno-associated viral vectors for CRISPR/Cas based in vivo therapeutic genome editing.工程化腺相关病毒载体用于基于CRISPR/Cas的体内治疗性基因组编辑
Biomaterials. 2025 Oct;321:123314. doi: 10.1016/j.biomaterials.2025.123314. Epub 2025 Apr 2.
9
Utilization of natural products in diverse pathogeneses of diseases associated with single or double DNA strand damage repair.天然产物在与单链或双链DNA损伤修复相关疾病的多种发病机制中的应用。
Chin Med. 2025 Apr 7;20(1):46. doi: 10.1186/s13020-025-01089-y.
10
Efficient nonviral integration of large transgenes into human T cells using Cas9-CLIPT.利用Cas9-CLIPT将大转基因高效非病毒整合到人类T细胞中。
Mol Ther Methods Clin Dev. 2025 Feb 18;33(1):101437. doi: 10.1016/j.omtm.2025.101437. eCollection 2025 Mar 13.
代谢工程为细胞治疗产生了无转基因的安全开关。
Nat Biotechnol. 2020 Dec;38(12):1441-1450. doi: 10.1038/s41587-020-0580-6. Epub 2020 Jul 13.
4
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.CRISPR 编辑的 T 细胞治疗难治性非小细胞肺癌患者的安全性和可行性。
Nat Med. 2020 May;26(5):732-740. doi: 10.1038/s41591-020-0840-5. Epub 2020 Apr 27.
5
Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell transplantation.供体 T 细胞的基因组编辑生成同种异体嵌合抗原受体修饰 T 细胞:优化 αβ T 细胞耗竭的单倍体相合造血干细胞移植。
Haematologica. 2021 Mar 1;106(3):847-858. doi: 10.3324/haematol.2019.233882.
6
Curing hemophilia A by NHEJ-mediated ectopic F8 insertion in the mouse.通过 NHEJ 介导的小鼠 F8 异位插入治疗 A 型血友病。
Genome Biol. 2019 Dec 16;20(1):276. doi: 10.1186/s13059-019-1907-9.
7
Advances in genome editing through control of DNA repair pathways.通过控制 DNA 修复途径实现基因组编辑的进展。
Nat Cell Biol. 2019 Dec;21(12):1468-1478. doi: 10.1038/s41556-019-0425-z. Epub 2019 Dec 2.
8
Predicting CRISPR/Cas9-Induced Mutations for Precise Genome Editing.预测 CRISPR/Cas9 诱导的突变以实现精确的基因组编辑。
Trends Biotechnol. 2020 Feb;38(2):136-141. doi: 10.1016/j.tibtech.2019.08.002. Epub 2019 Sep 13.
9
CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.经 CRISPR 编辑的干细胞在一名 HIV 合并急性淋巴细胞白血病患者中的应用。
N Engl J Med. 2019 Sep 26;381(13):1240-1247. doi: 10.1056/NEJMoa1817426. Epub 2019 Sep 11.
10
Simultaneous precise editing of multiple genes in human cells.在人类细胞中同时精确编辑多个基因。
Nucleic Acids Res. 2019 Nov 4;47(19):e116. doi: 10.1093/nar/gkz669.